お知らせ • Dec 17
Hydreight Updates on VSDHOne: Revolutionizing Direct-to-Consumer Healthcare Across All 50 States
Hydreight Technologies Inc. provided an update on VSDHOne, its Direct-to-Consumer healthcare platform. Now fully operational in all 50 states, VSDHOne is redefining telehealth by offering businesses an unparalleled, end-to-end solution to launch their own healthcare brands—quickly, cost-effectively, and at scale. VSDHOne provides a comprehensive telemedicine platform that empowers businesses, including MedSpas, health and wellness entrepreneurs, retailers, and pharmaceutical brands, to create D2C healthcare solutions in days rather than months. The purpose of launching VSDHOne is to make it easy for any existing brick and mortar or individuals to launch a direct to consumer healthcare brand in a few weeks without worrying about compliance, doctor network, telemedicine and ecommerce Technology, Medical direction and oversight, Pharmacy network, and a medical legal framework in all 50 States. With the marriage of Virtual and at facility healthcare features, Companies can expand beyond their current Bricks and Mortar solutions. Features include: eCommerce Platform, Telemedicine Technology, Booking and Scheduling Technology, Nationwide Doctors Network in all 50 States, Pharmacy Network and fulfillment partners, Medical Direction, Medical Legal Structure, Payment Processing, LegitScript approved - Enterprise Partner, Affiliate Marketing Automation, Available Treatments on the platform: There are currently about 40 products available on the platform for the clients to offer to their patients. VSDHOne supports a wide range of treatments tailored to meet growing consumer demand for convenient, personalized care. The platform currently offers: Skincare Treatments: Including acne and anti-aging solutions. Hair Loss Treatments: Clinically-backed therapies to promote hair regrowth. Sexual Health: Addressing common concerns with effective, discreet care. Hormone Replacement Therapy: Including Sermorelin and Testosterone Replacement Therapy. GLP-1 Weight Management: Cutting-edge treatments for obesity and weight management. Peptides. Future Treatments Coming to the Platform, Hydreight continues to expand VSDHOne’s offerings to include innovative therapies: Genetic Testing, Birth Control Options, Oral GLP-1 Therapies, NAD+ Nasal Spray for anti-aging and energy, Longevity-focused solutions. These treatments position VSDHOne as a comprehensive solution for a wide array of consumer healthcare needs, creating opportunities for businesses to grow their offerings and drive recurring patient engagement. Consumer trust in the healthcare system is at an all-time low. This is due to equal access to care and pricing. In certain states, there remains a significant limitation in accessing healthcare professionals. More than 80% of counties across the country lack access to services needed to maintain, much less improve, their health. That's approximately 30 million Americans who live in "healthcare deserts" where accessible physicians are scarce. Since the COVID-19 pandemic, the demand for telemedicine has surged, with adoption rates among physicians rising from 15.4% in 2019 to 86.5% in 2021. As telehealth continues to evolve, providers are expanding their services to include everything from live consultations to asynchronous treatments. There are many online providers for these treatments but they either are using different providers for different needs or they may not follow the best practices to have the full compliance. VSDHOne empowers providers from online providers, health clubs to existing brick and mortar locations to expand their offerings to consumers directly without being worried about the medical operational side of the offerings. They place a widget on their website and as soon as a patient lands on their website, they will go through the VSDHOne widget step by step platform and will receive their treatments and medications. VSDHOne operates on a SaaS-based model, with customers purchasing state-specific licenses and paying per-order fees for the platform’s end-to-end capabilities. This provides Hydreight with a recurring revenue stream while offering clients unparalleled scalability. Since its soft launch in late Second Quarter 2024, VSDHOne has been onboarding over 200 licenses, far exceeding expectations. The platform and management projects to have over 1,000 licenses by December 2025, creating significant recurring revenue opportunities. VSDHOne team is projecting each license to process approximately between 5 to 20 orders per day after full onboarding. The company will aim to provide guidance to the market by the end of First Quarter after fully onboarding the first group of licenses and monitoring their traction in the first months. Most of the orders and treatments are ongoing treatments that patients need to have follow up orders every month after the initial month.